Noema Pharma AG

Noema Pharma is a clinical-stage biopharmaceutical company focused on developing disease-transforming therapies for central nervous system (CNS) disorders. The company is advancing a late-stage portfolio of oral small molecule therapeutics aimed at delivering meaningful benefits to orphan and larger patient populations with debilitating neurological and related disorders of the brain and nervous system.